New Data for EGFR Inhibitors for Lung Cancer

Suresh S. Ramalingam, MD, a professor of medical oncology at the Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses data presented at the 2014 ASCO Annual Meeting examining EGFR inhibitors for lung cancer.

<<<

Back to the ASCO 2014 conference page